Pressrelease

Atley Solutions has successfully installed an Atley C100 module at Arronax, a world-leading nuclear medicine research institute in Nantes, France.

Atley Solutions and Nusano today announced a non-exclusive memorandum of understanding (MOU) to co-develop astatine-211 (At-211) solutions for the rapidly emerging applications of the isotope in oncology therapeutics.

Atley Solutions announces the first sale, delivery and installation of the Atley C100 to a US based biotech customer.

In a featured article in the local news media Nya Wermlands-tidningen (NWT) Atley Solutions’ recent development and future expansion plans are highlighted.

Atley Solutions has for the third time been selected as one of Sweden’s 33 best startup companies in the prestigious “33-listan” presented by the magazine NyTeknik.

Atley Solutions has delivered and installed the first commercial unit at Minerva Imaging’s facilities in Denmark.

Atley Solutions announces the launch of the Atley C100, the world’s first commercial module specifically designed for the manufacturing of At-211 (astatine-211) radiopharmaceuticals.

Atley Solutions partners with GE HealthCare and a European consortium to expand the use of theranostics in cancer care, with a specific focus on improving the supply and production of astatine-211 radiopharmaceuticals.

Atley secures largest funding round ever through investments from existing owners Chalmers Ventures, Marinvest, Vätterledens Ventures and Erik Strömqvist, as well as new investors such as Triathlon Ventures, Life Science Invest (LSI Epsilon), and Ekeblad Bostad.

Atley Solutions has raised 13,7 million SEK in a new share issue.